- ATC code L01
A section of the
Anatomical Therapeutic Chemical Classification System .L Antineoplastic and immunomodulating agents
L01A
Alkylating agent sL01AA
Nitrogen mustard analogues:L01AA01
Cyclophosphamide :L01AA02Chlorambucil :L01AA03Melphalan :L01AA05Chlormethine :L01AA06Ifosfamide :L01AA07Trofosfamide :L01AA08Prednimustine L01AB Alkyl sulfonates
:L01AB01
Busulfan :L01AB02Treosulfan :L01AB03Mannosulfan L01AC Ethylene imines
:L01AC01
Thiotepa :L01AC02Triaziquone :L01AC03Carboquone L01AD
Nitrosourea s:L01AD01
Carmustine :L01AD02Lomustine :L01AD03Semustine :L01AD04Streptozocin :L01AD05Fotemustine :L01AD06Nimustine :L01AD07Ranimustine L01AG
Epoxide s:L01AG01
Etoglucid L01AX Other alkylating agents
:L01AX01
Mitobronitol :L01AX02Pipobroman :L01AX03Temozolomide :L01AX04Dacarbazine L01B
Antimetabolite sL01BA
Folic acid analogues:L01BA01
Methotrexate :L01BA03Raltitrexed :L01BA04Pemetrexed L01BB
Purine analogues:L01BB02
Mercaptopurine :L01BB03Tioguanine :L01BB04Cladribine :L01BB05Fludarabine :L01BB06Clofarabine L01BC
Pyrimidine analogues:L01BC01
Cytarabine :L01BC02Fluorouracil :L01BC03Tegafur :L01BC04Carmofur :L01BC05Gemcitabine :L01BC06Capecitabine :L01BC52 Fluorouracil, combinations:L01BC53 Tegafur, combinationsL01C Plant
alkaloid s and other natural productsL01CA
Vinca alkaloids and analogues:L01CA01
Vinblastine :L01CA02Vincristine :L01CA03Vindesine :L01CA04Vinorelbine L01CB
Podophyllotoxin derivatives:L01CB01
Etoposide :L01CB02Teniposide L01CC
Colchicine derivatives:L01CC01
Demecolcine L01CD
Taxane s:L01CD01
Paclitaxel :L01CD02Docetaxel L01CX Other plant alkaloids and natural products
:L01CX01
Trabectedin L01D
Cytotoxic antibiotics and related substancesL01DA
Actinomycine s:L01DA01
Dactinomycin L01DB
Anthracycline s and related substances:L01DB01
Doxorubicin :L01DB02Daunorubicin :L01DB03Epirubicin :L01DB04Aclarubicin :L01DB05Zorubicin :L01DB06Idarubicin :L01DB07Mitoxantrone :L01DB08Pirarubicin :L01DB09Valrubicin L01DC Other cytotoxic antibiotics
:L01DC01
Bleomycin :L01DC02Plicamycin :L01DC03Mitomycin L01X Other antineoplastic agents
L01XA
Platinum compounds:L01XA01
Cisplatin :L01XA02Carboplatin :L01XA03Oxaliplatin L01XB
Methylhydrazine s:L01XB01
Procarbazine L01XC
Monoclonal antibodies :L01XC01
Edrecolomab :L01XC02Rituximab :L01XC03Trastuzumab :L01XC04Alemtuzumab :L01XC05Gemtuzumab :L01XC06Cetuximab :L01XC07Bevacizumab :L01XC08Panitumumab
=L01XDSensitizers used in Photodynamic/Radiation therapy=:L01XD01
Porfimer sodium :L01XD02Verteporfin :L01XD03Methyl aminolevulinate :L01XD04Aminolevulinic acid :L01XD05Temoporfin :L01XD06Efaproxiral L01XE
Protein kinase inhibitors :L01XE01
Imatinib :L01XE02Gefitinib :L01XE03Erlotinib :L01XE04Sunitinib :L01XE05Sorafenib :L01XE06Dasatinib L01XX Other antineoplastic agents
:L01XX01
Amsacrine :L01XX02Asparaginase :L01XX03Altretamine :L01XX05Hydroxycarbamide :L01XX07Lonidamine :L01XX08Pentostatin :L01XX09Miltefosine :L01XX10Masoprocol :L01XX11Estramustine :L01XX14Tretinoin :L01XX16Mitoguazone :L01XX17Topotecan :L01XX18Tiazofurine :L01XX19Irinotecan :L01XX22Alitretinoin :L01XX23Mitotane :L01XX24Pegaspargase :L01XX25Bexarotene :L01XX27Arsenic trioxide :L01XX28Imatinib :L01XX29Denileukin diftitox :L01XX31Gefitinib :L01XX32Bortezomib :L01XX33Celecoxib :L01XX34Erlotinib :L01XX35Anagrelide L01XY Combinations of antineoplastic agents
Wikimedia Foundation. 2010.